Portfolio Holdings Detail for ISIN IE000G2LIHG9
Stock Name / Fund iShares MSCI USA ESG Screened UCITS ETF EUR Hedged (Acc)
Issuer Blackrock
Entity holding fund iShares IV Public Limited Company
Entity Type
Entity LEI 549300ZP07LMR36K1T02
ETF Ticker SAUA(EUR) ETF Plus

Holdings detail for LLY

Stock Name	Eli Lilly and Company
Ticker	LLY(EUR) F
TYPE	Common Stock
Country	Germany
ISIN	US5324571083
LEI	FRDRIPF3EKNDJ2CQJL29

Show aggregate LLY holdings

News associated with LLY

Notable Friday Option Activity: AMD, LLY, BKNG: Looking at options trading activity among components of the S&P 500 index, there is noteworthy activity today in Advanced Micro Devices Inc (Symbol: AMD), where a total volume of 570,924 contracts has been traded thus far today, a contract volume which is representative of a - 2025-09-19 14:45:00
Boost Your Portfolio With These Top-Ranked ETFs: With the Fed's first 2025 rate cut and upgraded growth outlook, ETFs in tech, financials, industrials and health care could benefit from momentum. - 2025-09-19 13:03:00
3 Dividend Growth Stocks You Can Buy and Forget About: Key PointsThese stocks offer seemingly low yields of less than 1%. - 2025-09-18 05:50:00
JPMorgan Chase & Co. Has Lowered Expectations for Eli Lilly and Company (NYSE:LLY) Stock Price: Eli Lilly and Company (NYSE:LLY – Get Free Report) had its price objective decreased by JPMorgan Chase & Co. from $1,100.00 to $1,050.00 in a research report issued on Tuesday,Benzinga reports. The brokerage presently has an “overweight” rating on the stock. JPMorgan Chase & Co.‘s price target indicates a potential upside of 38.09% from the […] - 2025-09-18 02:56:56
Lilly's Orforglipron Achieves Significant Weight Loss In Phase 3 Trial: (RTTNews) - Eli Lilly and Co. (LLY) announced detailed results from its Phase 3 ATTAIN-1 trial, evaluating the safety and efficacy of orforglipron—an investigational oral glucagon-like peptide-1 (GLP-1) receptor agonist—in adults with obesity, or those overweight with a weight-re - 2025-09-17 00:35:16
XLV, LLY, TMO, PFE: Large Inflows Detected at ETF: Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the The Health Care Select Sector SPDR Fund (Symbol: XLV) where we have detected an approximate $308.0 million dollar inflow -- that's a 0.9% increase we - 2025-09-16 11:47:58
S&P 500 Analyst Moves: LLY: The latest tally of analyst opinions from the major brokerage houses shows that among the components of the S&P 500 index, Eli Lilly is now the #61 analyst pick, moving up by 1 spot. This rank is formed by averaging the analyst opinions for each component from each - 2025-09-15 14:35:56
Why Novo Nordisk Stock Popped Today: Key PointsLondon's Financial Times highlights improved weight loss from taking more Ozempic. - 2025-09-15 12:34:46
Sen. John Boozman Buys Eli Lilly and Company (NYSE:LLY) Stock: Senator John Boozman (R-Arkansas) recently bought shares of Eli Lilly and Company (NYSE:LLY). In a filing disclosed on September 12th, the Senator disclosed that they had bought between $1,001 and $15,000 in Eli Lilly and Company stock on August 11th. Senator John Boozman also recently made the following trade(s): Purchased $1,001 – $15,000 in shares […] - 2025-09-15 03:12:42
3 Monster Stocks to Hold for the Next 5 Years: Key PointsAmazon should improve its profits and margins, based on its cloud computing and AI initiatives. - 2025-09-14 08:45:00
2 Beaten-Down Stocks to Buy and Hold Forever: Key PointsApple and Eli Lilly have impressive long-term track records of returns. - 2025-09-13 08:45:00
2 Monster Stocks to Hold for the Next 5 Years: Key PointsThese stocks have climbed in the triple digits over the past three years. - 2025-09-11 05:20:00
IWB, LLY, ORCL, CVX: Large Inflows Detected at ETF: Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the iShares Russell 1000 ETF (Symbol: IWB) where we have detected an approximate $462.9 million dollar inflow -- that's a 1.1% increase week over week in - 2025-09-08 12:03:03
Down 34%, Should You Buy the Dip on Viking Therapeutics?: Key PointsViking Therapeutics is working on an injectable weight loss drug candidate and one in pill format. - 2025-09-05 05:10:00
The 6 Best Stocks to Buy Right Now in September (2025)!: My list of best stocks to buy has outperformed the broader market indexes by a significant margin. - 2025-09-04 06:00:00
The Problem With Weight Loss Stocks: In this Motley Fool Money episode, Motley Fool analysts Rick Munarriz and Karl Thiel and contributor Jason Hall dig into the problems with weight loss stocks. They also look at some investments that can survive near-term potential volatility as well as give a long-term view of di - 2025-09-03 14:48:00
NVO's Wegovy vs. LLY's Tirzepatide: Who Leads in Heart Risk Reduction?: Novo Nordisk's Wegovy shows a stronger reduction in heart risks compared to Eli Lilly's tirzepatide in real-world data from the STEER study. - 2025-09-01 11:54:00
The Zacks Analyst Blog Highlights Lilly, Oracle, Procter & Gamble and Comstock Holding Companies: Zacks spotlights Eli Lilly, Oracle, Procter & Gamble, and microcap Comstock Holding, with pharma and staples facing pressure while Oracle and Comstock show momentum. - 2025-08-29 13:58:00
Nvidia's $46.7 Billion Quarter Shows the AI Trade Is Alive and Well -- With Caveats: Key PointsWhile earnings were up 56%, the company's data center revenue dropped 1% sequentially. - 2025-08-29 05:45:00
Top Stock Reports for Eli Lilly, Oracle & Procter & Gamble: Today's Research Daily features new research reports on 16 major stocks, including Eli Lilly, Oracle, and Procter & Gamble, as well as a micro-cap stock, Comstock. - 2025-08-28 18:59:00
2 Growth Stocks That Could Be Worth $1 Trillion in 5 Years: Key PointsEli Lilly's work in weight management should help it surpass some industry sales records. - 2025-08-28 10:45:00
2 High-Yield Dividend Stocks You Can Buy With $200 Now and Hold at Least a Decade: Key PointsDividend-paying stocks tend to outperform non-dividend-paying stocks by a mile. - 2025-08-28 04:26:00
As the Market Rotates, This Healthcare ETF Is Leading the Way: Over the past month, the market has undergone a rotation that’s seen tech sell-off and defensive sectors like healthcare reap the rewards. The jury remains out on whether this shift indicates a more inclusive rally or if it should raise questions about the bull market’s footing. - 2025-08-26 10:35:00
When AI Execs Say the Market Looks Bubbly: In this podcast, Motley Fool contributors Tyler Crowe, Lou Whiteman, and Rachel Warren discuss: - 2025-08-25 14:47:00
Eli Lilly and Company (NYSE:LLY) and Innoviva (NASDAQ:INVA) Financial Analysis: Eli Lilly and Company (NYSE:LLY – Get Free Report) and Innoviva (NASDAQ:INVA – Get Free Report) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, institutional ownership, profitability, valuation, risk, dividends and earnings. Institutional & Insider Ownership 82.5% of Eli […] - 2025-08-25 04:38:49
The S&P 500 Hasn't Yielded This Little Since the Dot-Com Bubble. Here's What Investors Can Do.: Key PointsThe S&P 500's rising yield is similar to what happened before the dot-com bubble burst. - 2025-08-24 15:23:00
The Best Stocks to Invest $50,000 in Right Now: Key PointsIf you have a lump sum of money, look for long-term performance and stability. - 2025-08-24 05:32:00
If I Could Only Buy 1 S&P 500 Stock From Each Sector for the Rest of 2025, I'd Go With These 11 Dividend Stocks: Key PointsSome stock market sectors significantly impact the S&P 500, whereas others barely make a dent. - 2025-08-23 19:05:00
Is the Vanguard Mega Cap ETF the Simplest Way to Invest in the Top S&P 500 Stocks?: Key PointsThe fund targets the 37% largest S&P 500 components by market cap. - 2025-08-23 17:05:00
Warren Buffett Makes a Big Buy: In this podcast, Motley Fool contributors Travis Hoium, Lou Whiteman, and Rick Munarriz discuss: - 2025-08-22 17:55:00

iShares MSCI USA ESG Screened UCITS ETF EUR Hedged (Acc) LLY holdings

Date	Number of LLY Shares Held	Base Market Value of LLY Shares	Local Market Value of LLY Shares	Change in LLY Shares Held	Change in LLY Base Value	Current Price per LLY Share Held	Previous Price per LLY Share Held
2025-09-18 (Thursday)	233,723	USD 178,314,288	USD 178,314,288	612	USD 1,119,624	USD 762.93	USD 760.13
2025-09-17 (Wednesday)	233,111	USD 177,194,664	USD 177,194,664	765	USD -482,646	USD 760.13	USD 764.71
2025-09-16 (Tuesday)	232,346	USD 177,677,310	USD 177,677,310	1,224	USD 4,754,141	USD 764.71	USD 748.19
2025-09-15 (Monday)	231,122	USD 172,923,169	USD 172,923,169	408	USD -1,355,879	USD 748.19	USD 755.39
2025-09-12 (Friday)	230,714	USD 174,279,048	USD 174,279,048	0	USD -205,336	USD 755.39	USD 756.28
2025-09-11 (Thursday)	230,714	USD 174,484,384	USD 174,484,384	-51	USD 344,500	USD 756.28	USD 754.62
2025-09-10 (Wednesday)	230,765	USD 174,139,884	USD 174,139,884	3,264	USD 3,375,358	USD 754.62	USD 750.61
2025-09-09 (Tuesday)	227,501	USD 170,764,526	USD 170,764,526	200	USD 2,870,915	USD 750.61	USD 738.64

Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of LLY by Blackrock for IE000G2LIHG9

Show aggregate share trades of LLY

Date Action Quantity Market High Market Low Likely Trade Price Likely Trade Value (Profit/Loss) Average Price previous trades
2025-09-18 BUY 612 762.930* 798.90
2025-09-17 BUY 765 760.130* 799.09
2025-09-16 BUY 1,224 764.710* 799.26
2025-09-15 BUY 408 748.190* 799.52
2025-09-11 SELL -51 756.280* 799.97 Profit of 40,798 on sale
2025-09-10 BUY 3,264 754.620* 800.20
2025-09-09 BUY 200 750.610* 800.45
2025-08-06 BUY 963 746.370* 801.57
2025-07-31 BUY 255 740.070* 802.08
2025-07-29 BUY 1,020 762.950* 802.51
2025-07-28 BUY 204 808.110* 802.48
2025-07-25 BUY 306 812.690* 802.42
2025-07-24 BUY 150 805.430* 802.41
2025-07-23 BUY 357 798.890* 802.43
2025-07-22 BUY 204 776.440* 802.57
2025-07-18 BUY 408 771.710* 802.74
2025-07-17 BUY 1,403 761.500* 802.97
2025-07-11 BUY 408 793.010* 803.29
2025-07-10 BUY 459 790.650* 803.37
2025-07-09 BUY 459 786.920* 803.46
2025-07-07 SELL -306 772.870* 803.79 Profit of 245,959 on sale
2025-07-02 SELL -1,275 779.280* 804.20 Profit of 1,025,358 on sale
2025-06-27 BUY 143 775.450* 804.52
2025-06-26 BUY 153 795.120* 804.58
2025-06-24 SELL -714 778.080* 804.81 Profit of 574,635 on sale
2025-06-18 BUY 408 785.030* 805.53
2025-06-17 BUY 153 791.240* 805.62
2025-06-16 SELL -208 807.580* 805.61 Profit of 167,566 on sale
2025-06-13 BUY 435 819.360* 805.52
2025-06-12 SELL -255 812.030* 805.48 Profit of 205,397 on sale
2025-06-11 BUY 545 808.610* 805.46
2025-06-06 BUY 153 769.880* 805.89
2025-06-05 BUY 714 765.680* 806.15
2025-06-04 BUY 102 765.840* 806.42
2025-06-03 SELL -51 750.780* 806.79 Profit of 41,146 on sale
2025-05-30 SELL -5,245 737.670* 807.66 Profit of 4,236,180 on sale
2025-05-29 BUY 137 722.570* 808.24
2025-05-27 BUY 879 725.220* 809.42
2025-05-23 BUY 705 713.710* 810.76
2025-05-22 BUY 357 715.200* 811.44
2025-05-19 BUY 306 755.110* 812.93
2025-05-16 BUY 153 757.390* 813.33
2025-05-15 SELL -102 733.290* 813.91 Profit of 83,019 on sale
2025-05-14 BUY 51 715.560* 814.64
2025-05-13 BUY 102 746.060* 815.15
2025-05-12 BUY 347 755.570* 815.59
2025-05-09 SELL -255 734.570* 816.20 Profit of 208,131 on sale
2025-05-08 BUY 102 751.450* 816.69
2025-05-07 BUY 153 776.720* 816.99
2025-05-02 BUY 5,661 823.620* 817.24
2025-04-30 BUY 1,785 898.950* 816.77
2025-04-29 BUY 447 885.200* 816.22
2025-04-28 BUY 357 877.290* 815.73
2025-04-25 BUY 918 884.540* 815.17
2025-04-24 SELL -1,071 859.730* 814.81 Profit of 872,657 on sale
2025-04-23 BUY 969 829.420* 814.68
2025-04-22 BUY 408 827.540* 814.58
2025-04-17 BUY 561 839.960* 814.11
2025-04-15 BUY 510 757.180* 815.30
2025-04-11 BUY 1,674 732.410* 816.57
2025-04-09 BUY 306 753.710* 818.00
2025-04-08 BUY 1,836 726.240* 818.83
2025-04-07 BUY 600 723.730* 819.71
2025-04-04 SELL -816 738.210* 820.46 Profit of 669,496 on sale
2025-04-02 BUY 6,936 818.220* 820.48
2025-04-01 BUY 51 805.230* 820.63
2025-03-31 BUY 357 825.910* 820.58
2025-03-28 BUY 204 822.510* 820.56
2025-03-27 BUY 94 821.670* 820.55
2025-03-26 BUY 51 826.760* 820.48
2025-03-25 BUY 549 852.350* 820.17
2025-03-24 BUY 611 864.900* 819.72
2025-03-21 SELL -204 837.570* 819.54 Profit of 167,186 on sale
2025-03-20 BUY 816 842.570* 819.31
2025-03-19 BUY 141 837.010* 819.12
2025-03-18 BUY 1,756 822.510* 819.09
2025-03-17 BUY 357 824.760* 819.03
2025-03-14 BUY 2,652 813.480* 819.09
2025-03-13 BUY 510 801.650* 819.28
2025-03-12 SELL -2,550 821.860* 819.25 Profit of 2,089,081 on sale
2025-03-11 SELL -1,887 824.060* 819.19 Profit of 1,545,820 on sale
2025-03-10 BUY 561 829.760* 819.08
2025-03-07 BUY 102 869.580* 818.51
2025-03-05 BUY 765 929.720* 817.25
2025-03-04 BUY 867 911.060* 816.17
2025-03-03 BUY 1,632 929.720* 814.85
2025-02-28 BUY 1,326 920.630* 813.60
2025-02-27 SELL -255 905.160* 812.51 Profit of 207,191 on sale
2025-02-25 BUY 1,887 901.800* 810.17
2025-02-21 BUY 204 873.680* 808.49
2025-02-18 SELL -459 857.200* 806.26 Profit of 370,072 on sale
2025-02-14 SELL -3,111 844.270* 805.24 Profit of 2,505,114 on sale
2025-02-13 BUY 51 871.860* 804.34
2025-02-12 BUY 502 872.970* 803.40
2025-02-07 SELL -71 878.310* 800.52 Profit of 56,837 on sale
2025-02-06 BUY 969 870.370* 799.51
2025-02-05 BUY 255 842.180* 798.88
2025-02-04 BUY 306 826.070* 798.47
2025-02-03 BUY 306 810.430* 798.29
2025-01-31 BUY 561 811.080* 798.09
2025-01-29 SELL -51 804.080* 797.60 Profit of 40,678 on sale
2025-01-28 SELL -459 804.990* 797.48 Profit of 366,044 on sale
2025-01-27 SELL -816 808.170* 797.31 Profit of 650,602 on sale
2025-01-24 BUY 612 785.410* 797.50
2025-01-23 BUY 102 766.600* 798.03
2025-01-22 BUY 839 753.980* 798.79
2025-01-21 BUY 612 742.350* 799.78
2025-01-16 BUY 944 757.600* 803.30
2025-01-14 BUY 408 744.910* 805.51
2025-01-10 BUY 1,224 799.900* 805.79
2024-12-30 BUY 153 773.840* 808.69
2024-12-27 BUY 204 783.170* 809.27
2024-12-23 BUY 1,530 796.280* 810.28
2024-12-20 BUY 408 767.760* 811.35
2024-12-19 BUY 51 757.540* 812.73
2024-12-18 BUY 408 764.710* 813.99
2024-12-17 BUY 102 778.620* 814.95
2024-12-16 BUY 510 779.000* 815.95
2024-12-13 BUY 368 789.120* 816.71
2024-12-10 BUY 2,550 799.580* 817.86
2024-12-09 BUY 306 803.580* 818.30
2024-12-06 SELL -765 826.710* 818.03 Profit of 625,795 on sale
2024-12-05 SELL -51 825.620* 817.78 Profit of 41,707 on sale
2024-12-03 BUY 255 813.330* 817.51
2024-11-27 SELL -306 788.190* 821.61 Profit of 251,413 on sale
2024-11-26 BUY 1,071 789.320* 823.02
2024-11-25 BUY 1,337 755.000* 826.11
2024-11-22 SELL -94 748.010* 829.83 Profit of 78,004 on sale
2024-11-21 SELL -250 749.920* 833.82 Profit of 208,455 on sale
2024-11-20 SELL -100 753.410* 838.05 Profit of 83,805 on sale
2024-11-19 BUY 50 729.730* 844.07
2024-11-18 BUY 412 727.200* 850.95
2024-11-11 BUY 150 832.440* 854.32
2024-11-07 BUY 138 797.450* 860.45
2024-11-06 BUY 1,200 776.380* 867.45
2024-11-05 BUY 250 806.060* 873.03
2024-11-04 BUY 94 806.140* 879.72
2024-11-01 BUY 141 818.930* 886.48
2024-10-30 SELL -300 846.830* 900.25 Profit of 270,074 on sale
2024-10-29 SELL -900 903.580* 899.69 Profit of 809,721 on sale
2024-10-28 SELL -350 895.590* 900.51 Profit of 315,179 on sale
2024-10-21 SELL -50 906.130* 0.00
Market high and low price is on the date.

Date	Action	Quantity	Likely Trade Price	Average Price previous trades
2025-09-18	BUY	612	762.930*	798.90
2025-09-17	BUY	765	760.130*	799.09
2025-09-16	BUY	1,224	764.710*	799.26
2025-09-15	BUY	408	748.190*	799.52
2025-09-11	SELL	-51	756.280*	799.97 Profit of 40,798 on sale
2025-09-10	BUY	3,264	754.620*	800.20
2025-09-09	BUY	200	750.610*	800.45
2025-08-06	BUY	963	746.370*	801.57
2025-07-31	BUY	255	740.070*	802.08
2025-07-29	BUY	1,020	762.950*	802.51
2025-07-28	BUY	204	808.110*	802.48
2025-07-25	BUY	306	812.690*	802.42
2025-07-24	BUY	150	805.430*	802.41
2025-07-23	BUY	357	798.890*	802.43
2025-07-22	BUY	204	776.440*	802.57
2025-07-18	BUY	408	771.710*	802.74
2025-07-17	BUY	1,403	761.500*	802.97
2025-07-11	BUY	408	793.010*	803.29
2025-07-10	BUY	459	790.650*	803.37
2025-07-09	BUY	459	786.920*	803.46
2025-07-07	SELL	-306	772.870*	803.79 Profit of 245,959 on sale
2025-07-02	SELL	-1,275	779.280*	804.20 Profit of 1,025,358 on sale
2025-06-27	BUY	143	775.450*	804.52
2025-06-26	BUY	153	795.120*	804.58
2025-06-24	SELL	-714	778.080*	804.81 Profit of 574,635 on sale
2025-06-18	BUY	408	785.030*	805.53
2025-06-17	BUY	153	791.240*	805.62
2025-06-16	SELL	-208	807.580*	805.61 Profit of 167,566 on sale
2025-06-13	BUY	435	819.360*	805.52
2025-06-12	SELL	-255	812.030*	805.48 Profit of 205,397 on sale
2025-06-11	BUY	545	808.610*	805.46
2025-06-06	BUY	153	769.880*	805.89
2025-06-05	BUY	714	765.680*	806.15
2025-06-04	BUY	102	765.840*	806.42
2025-06-03	SELL	-51	750.780*	806.79 Profit of 41,146 on sale
2025-05-30	SELL	-5,245	737.670*	807.66 Profit of 4,236,180 on sale
2025-05-29	BUY	137	722.570*	808.24
2025-05-27	BUY	879	725.220*	809.42
2025-05-23	BUY	705	713.710*	810.76
2025-05-22	BUY	357	715.200*	811.44
2025-05-19	BUY	306	755.110*	812.93
2025-05-16	BUY	153	757.390*	813.33
2025-05-15	SELL	-102	733.290*	813.91 Profit of 83,019 on sale
2025-05-14	BUY	51	715.560*	814.64
2025-05-13	BUY	102	746.060*	815.15
2025-05-12	BUY	347	755.570*	815.59
2025-05-09	SELL	-255	734.570*	816.20 Profit of 208,131 on sale
2025-05-08	BUY	102	751.450*	816.69
2025-05-07	BUY	153	776.720*	816.99
2025-05-02	BUY	5,661	823.620*	817.24
2025-04-30	BUY	1,785	898.950*	816.77
2025-04-29	BUY	447	885.200*	816.22
2025-04-28	BUY	357	877.290*	815.73
2025-04-25	BUY	918	884.540*	815.17
2025-04-24	SELL	-1,071	859.730*	814.81 Profit of 872,657 on sale
2025-04-23	BUY	969	829.420*	814.68
2025-04-22	BUY	408	827.540*	814.58
2025-04-17	BUY	561	839.960*	814.11
2025-04-15	BUY	510	757.180*	815.30
2025-04-11	BUY	1,674	732.410*	816.57
2025-04-09	BUY	306	753.710*	818.00
2025-04-08	BUY	1,836	726.240*	818.83
2025-04-07	BUY	600	723.730*	819.71
2025-04-04	SELL	-816	738.210*	820.46 Profit of 669,496 on sale
2025-04-02	BUY	6,936	818.220*	820.48
2025-04-01	BUY	51	805.230*	820.63
2025-03-31	BUY	357	825.910*	820.58
2025-03-28	BUY	204	822.510*	820.56
2025-03-27	BUY	94	821.670*	820.55
2025-03-26	BUY	51	826.760*	820.48
2025-03-25	BUY	549	852.350*	820.17
2025-03-24	BUY	611	864.900*	819.72
2025-03-21	SELL	-204	837.570*	819.54 Profit of 167,186 on sale
2025-03-20	BUY	816	842.570*	819.31
2025-03-19	BUY	141	837.010*	819.12
2025-03-18	BUY	1,756	822.510*	819.09
2025-03-17	BUY	357	824.760*	819.03
2025-03-14	BUY	2,652	813.480*	819.09
2025-03-13	BUY	510	801.650*	819.28
2025-03-12	SELL	-2,550	821.860*	819.25 Profit of 2,089,081 on sale
2025-03-11	SELL	-1,887	824.060*	819.19 Profit of 1,545,820 on sale
2025-03-10	BUY	561	829.760*	819.08
2025-03-07	BUY	102	869.580*	818.51
2025-03-05	BUY	765	929.720*	817.25
2025-03-04	BUY	867	911.060*	816.17
2025-03-03	BUY	1,632	929.720*	814.85
2025-02-28	BUY	1,326	920.630*	813.60
2025-02-27	SELL	-255	905.160*	812.51 Profit of 207,191 on sale
2025-02-25	BUY	1,887	901.800*	810.17
2025-02-21	BUY	204	873.680*	808.49
2025-02-18	SELL	-459	857.200*	806.26 Profit of 370,072 on sale
2025-02-14	SELL	-3,111	844.270*	805.24 Profit of 2,505,114 on sale
2025-02-13	BUY	51	871.860*	804.34
2025-02-12	BUY	502	872.970*	803.40
2025-02-07	SELL	-71	878.310*	800.52 Profit of 56,837 on sale
2025-02-06	BUY	969	870.370*	799.51
2025-02-05	BUY	255	842.180*	798.88
2025-02-04	BUY	306	826.070*	798.47
2025-02-03	BUY	306	810.430*	798.29
2025-01-31	BUY	561	811.080*	798.09
2025-01-29	SELL	-51	804.080*	797.60 Profit of 40,678 on sale
2025-01-28	SELL	-459	804.990*	797.48 Profit of 366,044 on sale
2025-01-27	SELL	-816	808.170*	797.31 Profit of 650,602 on sale
2025-01-24	BUY	612	785.410*	797.50
2025-01-23	BUY	102	766.600*	798.03
2025-01-22	BUY	839	753.980*	798.79
2025-01-21	BUY	612	742.350*	799.78
2025-01-16	BUY	944	757.600*	803.30
2025-01-14	BUY	408	744.910*	805.51
2025-01-10	BUY	1,224	799.900*	805.79
2024-12-30	BUY	153	773.840*	808.69
2024-12-27	BUY	204	783.170*	809.27
2024-12-23	BUY	1,530	796.280*	810.28
2024-12-20	BUY	408	767.760*	811.35
2024-12-19	BUY	51	757.540*	812.73
2024-12-18	BUY	408	764.710*	813.99
2024-12-17	BUY	102	778.620*	814.95
2024-12-16	BUY	510	779.000*	815.95
2024-12-13	BUY	368	789.120*	816.71
2024-12-10	BUY	2,550	799.580*	817.86
2024-12-09	BUY	306	803.580*	818.30
2024-12-06	SELL	-765	826.710*	818.03 Profit of 625,795 on sale
2024-12-05	SELL	-51	825.620*	817.78 Profit of 41,707 on sale
2024-12-03	BUY	255	813.330*	817.51
2024-11-27	SELL	-306	788.190*	821.61 Profit of 251,413 on sale
2024-11-26	BUY	1,071	789.320*	823.02
2024-11-25	BUY	1,337	755.000*	826.11
2024-11-22	SELL	-94	748.010*	829.83 Profit of 78,004 on sale
2024-11-21	SELL	-250	749.920*	833.82 Profit of 208,455 on sale
2024-11-20	SELL	-100	753.410*	838.05 Profit of 83,805 on sale
2024-11-19	BUY	50	729.730*	844.07
2024-11-18	BUY	412	727.200*	850.95
2024-11-11	BUY	150	832.440*	854.32
2024-11-07	BUY	138	797.450*	860.45
2024-11-06	BUY	1,200	776.380*	867.45
2024-11-05	BUY	250	806.060*	873.03
2024-11-04	BUY	94	806.140*	879.72
2024-11-01	BUY	141	818.930*	886.48
2024-10-30	SELL	-300	846.830*	900.25 Profit of 270,074 on sale
2024-10-29	SELL	-900	903.580*	899.69 Profit of 809,721 on sale
2024-10-28	SELL	-350	895.590*	900.51 Profit of 315,179 on sale
2024-10-21	SELL	-50	906.130*	0.00

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of LLY

Date	Shorted Volume	Short Exempt Volume	Total Shares Traded	% Shorted
2025-09-19	432,038	935	1,319,853	32.7%
2025-09-18	547,818	126	1,290,147	42.5%
2025-09-17	437,337	427	1,166,204	37.5%
2025-09-16	532,698	1,829	1,463,374	36.4%
2025-09-15	424,979	701	1,071,487	39.7%
2025-09-12	267,121	172	826,802	32.3%
2025-09-11	249,803	1,484	850,461	29.4%
2025-09-10	415,442	1,025	989,008	42.0%
2025-09-09	559,805	667	1,270,800	44.1%
2025-09-08	856,018	4,682	1,937,447	44.2%
2025-09-05	679,276	1,050	1,405,239	48.3%
2025-09-04	337,491	53	982,751	34.3%
2025-09-03	214,691	496	766,157	28.0%
2025-09-02	430,477	2,977	1,131,908	38.0%
2025-08-29	357,538	602	889,509	40.2%
2025-08-28	433,687	1,099	1,113,568	38.9%
2025-08-27	860,715	6,009	1,681,353	51.2%
2025-08-26	1,548,460	12,105	2,955,348	52.4%
2025-08-25	566,454	3,586	1,323,249	42.8%
2025-08-22	749,615	1,957	1,460,713	51.3%
2025-08-21	651,639	223	1,570,067	41.5%
2025-08-20	679,554	2,698	1,870,241	36.3%
2025-08-19	787,909	935	2,788,740	28.3%
2025-08-18	756,143	1,095	1,727,603	43.8%
2025-08-15	1,814,721	836	3,422,260	53.0%
2025-08-14	1,852,940	5,382	3,602,829	51.4%
2025-08-13	1,254,225	3,473	2,774,100	45.2%
2025-08-12	990,110	3,190	2,845,896	34.8%
2025-08-11	1,290,063	1,615	5,196,302	24.8%
2025-08-08	2,448,706	300,870	6,239,830	39.2%
2025-08-07	4,197,951	489,618	10,364,294	40.5%
2025-08-06	440,144	1,120	1,811,262	24.3%
2025-08-05	331,460	921	993,178	33.4%
2025-08-04	474,905	1,408	1,273,995	37.3%
2025-08-01	530,569	7,139	1,882,098	28.2%
2025-07-31	882,506	3,670	2,110,030	41.8%
2025-07-30	745,614	392	1,827,435	40.8%
2025-07-29	1,081,849	571	2,607,245	41.5%
2025-07-28	304,841	7,460	1,004,032	30.4%
2025-07-25	365,417	265	1,055,273	34.6%
2025-07-24	321,799	762	1,167,147	27.6%
2025-07-23	485,719	3,471	1,044,919	46.5%
2025-07-22	241,098	3,036	874,717	27.6%
2025-07-21	418,014	854	1,180,445	35.4%
2025-07-18	623,498	651	1,225,333	50.9%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.

Stock Name / Fund	iShares MSCI USA ESG Screened UCITS ETF EUR Hedged (Acc)
Issuer	Blackrock
Entity holding fund	iShares IV Public Limited Company
Entity Type
Entity LEI	549300ZP07LMR36K1T02
ETF Ticker	SAUA(EUR) ETF Plus